Sorrento Therapeutics Competitors, Revenue, Alternatives and Pricing

Claim your profile


Total Funding:$365.3M
Lead Investor(s):Oaktree Capital Management

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Sorrento Therapeutics's estimated annual revenue is currently $21.2M per year.(?)
  • Sorrento Therapeutics received $150.0M in venture funding in November 2018.
  • Sorrento Therapeutics's estimated revenue per employee is $72,828
  • Sorrento Therapeutics's total funding is $365.3M.

Employee Data

  • Sorrento Therapeutics has 291 Employees.(?)
  • Sorrento Therapeutics grew their employee count by 12% last year.
  • Sorrento Therapeutics currently has 1 job openings.

Sorrento Therapeutics is an antibody-centric, clinical stage biopharmaceutical company developing new treatments for cancer, inflammation and autoimmune diseases. Sorrento's lead products are multiple late-stage biosimilar and biobetter antibodies, as well as clinical CAR-T therapies targeting solid tumors.